Kim Jin-wook CEO Acquires Additional 3,600 Shares in Prestige Bio-Logics

Prestige Bio-Logics (334970) CEO Kim Jin-wook purchased an additional 3,600 common shares on July 9 through a market buy. This brings his total holdings to 7.8152 million shares, maintaining a 10.05% stake. According to the July 10 disclosure, Kim is an registered officer and major shareholder, holding 7.8116 million shares as of June 30. The stock closed at 1,780 won on July 10, down 50 won (-2.73%) from the previous day. Recent financial results show revenue of 12.5 billion won, operating loss of 337 billion won, and net loss of 275 billion won. The company, listed on KOSDAQ since June 2, 2015, operates in the pharmaceutical manufacturing sector.